Combined therapy: RAS blocker + Calcium channel blocker
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Combined therapy: RAS blocker + Calcium channel blocker, covering 2009-06-17 to 2009-06-17. Get the full timeline:
Most recent: Clinical Trial Update: The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension [Phase 4]